Novozymes Acquires Delta Biotechnology Ltd

Molecular Designs Acquires Lamda Biotech

September 25, 2024

Biotechnology

Molecular Designs, a Birmingham-based provider of PCR assays and related reagents and equipment, has acquired Lamda Biotech, a St. Louis provider of molecular biology research products and kits. The deal will expand Molecular Designs’ product portfolio and manufacturing capacity while broadening access to academic research and pharmaceutical customers and strengthening R&D and technical talent.

Novozymes and Chr. Hansen Combine to Form Novonesis

January 29, 2024

Biotechnology

On January 29, 2024 Novozymes and Chr. Hansen completed a statutory merger to create Novonesis, a global biosolutions company focused on enzymes, cultures and microbial solutions. The combined group will employ around 10,000 people worldwide and have pro forma annual revenue of approximately EUR 3.7 billion, with targeted synergies across food & health and planetary health portfolios.

Kerry Group to Acquire Lactase Enzyme Business from Chr. Hansen and Novozymes

December 14, 2023

Food & Beverage

Kerry Group PLC has agreed to acquire part of the global lactase enzyme business carved out from Chr. Hansen Holding A/S and Novozymes A/S for a total consideration of €150 million (subject to closing adjustments). The deal includes certain trade and assets of Chr. Hansen's global lactase business and 100% of Nuocheng Trillion Food (Tianjin) Co., Ltd.; the lactase business generated about €40 million in revenue in 2022 and the transaction is expected to close in the first half of 2024 subject to European Commission approval.

Novartis Acquires DTx Pharma

July 17, 2023

Biotechnology

Novartis has acquired DTx Pharma, a San Diego–based preclinical biotechnology company, for an upfront payment of USD 500 million plus contingent milestone payments. The deal brings DTx's FALCON siRNA delivery platform and lead program DTx-1252 (orphan-designated for CMT1A) into Novartis to strengthen its neuroscience pipeline and xRNA capabilities.

Astrea Bioseparations Acquires Delta Precision Ltd

January 9, 2023

Biotechnology

Astrea Bioseparations has acquired Delta Precision Ltd, a manufacturer of high-performance chromatography columns for the biotechnology and pharmaceutical industries. The acquisition expands Astrea Bio's product offering to include a full range of chromatography columns and accelerates its ability to develop and bring new purification technologies to biomanufacturing customers.

Novozymes A/S Agrees to Acquire GroPep Limited

August 15, 2006

Biotechnology

Novozymes A/S has proposed to acquire all issued securities of Australian biotech GroPep Limited via a scheme of arrangement, offering A$2.05 per share and valuing GroPep at approximately A$96 million. The transaction is subject to typical scheme and regulatory approvals, with completion expected by end of 2006, and is intended to expand Novozymes' biopharmaceutical/recombinant-ingredient capabilities and market access.